Development of Radioiodinated Tetrahydropyrazolopyridine Inhibitors Targeting mIDH.

Kaur S, Dukic-Stefanovic S, Arnaud L, Chezal JM, Wenzel B, Moldovan RP, Kopka K, Maisonial-Besset A

DOI: 10.1002/jlcr.70039
Published: 2026 Nov
Container: Journal of labelled compounds & radiopharmaceuticals
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jlcr.70039,
  title = {Development of Radioiodinated Tetrahydropyrazolopyridine Inhibitors Targeting mIDH.},
  author = {Kaur S and Dukic-Stefanovic S and Arnaud L and Chezal JM and Wenzel B and Moldovan RP and Kopka K and Maisonial-Besset A},
  year = {2026},
  journal = {Journal of labelled compounds \& radiopharmaceuticals},
  doi = {10.1002/jlcr.70039},
  url = {https://doi.org/10.1002/jlcr.70039}
}

RIS

TY  - JOUR
TI  - Development of Radioiodinated Tetrahydropyrazolopyridine Inhibitors Targeting mIDH.
AU  - Kaur S
AU  - Dukic-Stefanovic S
AU  - Arnaud L
AU  - Chezal JM
AU  - Wenzel B
AU  - Moldovan RP
AU  - Kopka K
AU  - Maisonial-Besset A
PY  - 2026
JO  - Journal of labelled compounds & radiopharmaceuticals
DO  - 10.1002/jlcr.70039
UR  - https://doi.org/10.1002/jlcr.70039
ER  -

APA

S, K., S, D., L, A., JM, C., B, W., RP, M., K, K., & A, M. (2026). Development of Radioiodinated Tetrahydropyrazolopyridine Inhibitors Targeting mIDH.. Journal of labelled compounds & radiopharmaceuticals. https://doi.org/10.1002/jlcr.70039

Source records

pubmed · retrieved 2026-11-10T10:30:25.455Z